Cell Source, Inc. SEC filings CLCS

Cell Source, Inc. has 139 filings in SEC EDGAR's recent list, going back to Mar 5, 2013. Its latest annual report, Form 10-K, was filed on Apr 7, 2026 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2025. The most recent current report (Form 8-K) was filed on Jun 27, 2025 (auditor change). The company's fiscal year ends on December 31.

Cell Source, Inc. SEC filings
Form Description Filed Period
3 Initial insider ownership Apr 21, 2022 Mar 10, 2022
4 Insider transaction Aug 11, 2021 Aug 9, 2021
4 Insider transaction Jul 7, 2021 Jun 30, 2021
4 Insider transaction Jul 7, 2021 Jun 30, 2021
4 Insider transaction Jul 7, 2021 Jun 30, 2021
4 Insider transaction Jul 7, 2021 Jun 30, 2021
4 Insider transaction Jun 10, 2021 May 18, 2017
4 Insider transaction Jun 10, 2021 May 18, 2017
SC 13D Ownership over 5% (active) Jun 10, 2021 —
4 Insider transaction Jun 10, 2021 Mar 8, 2021
4 Insider transaction Jun 10, 2021 Feb 13, 2019
SC 13D Ownership over 5% (active) Apr 21, 2021 —
3 Initial insider ownership Apr 20, 2021 Mar 25, 2021
SC 13G Ownership over 5% (passive) Dec 29, 2020 —
3 Initial insider ownership Dec 29, 2020 Aug 13, 2019
SC 13G Ownership over 5% (passive) Nov 17, 2020 —
4 Insider transaction Apr 14, 2016 Nov 9, 2015
4 Insider transaction Apr 14, 2016 Nov 9, 2015
4 Insider transaction Jul 22, 2015 Jul 20, 2015
3 Initial insider ownership Apr 1, 2015 Apr 1, 2015
3 Initial insider ownership Apr 1, 2015 Apr 1, 2015
3 Initial insider ownership Apr 1, 2015 Apr 1, 2015
3 Initial insider ownership Apr 1, 2015 Apr 1, 2015
3 Initial insider ownership Apr 1, 2015 Apr 1, 2015

Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CLCS (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1569340
Former names
TICKET TO SEE, INC. (until Jun 26, 2014)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.